Healthcare -
Biotechnology - NASDAQ - US
$ 2.45
6.52 %
$ 170 M
Market Cap
-0.79
P/E
IKT - CASH FROM OPERATIONS
Cash from Operations IKT - Inhibikase Therapeutics, Inc.
-18.1 M
LAST VALUE
-12.47%
2 YEAR CAGR
-92.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR